Literature DB >> 2475494

Inter-alpha-trypsin inhibitor. Inhibition spectrum of native and derived forms.

J Potempa1, K Kwon, R Chawla, J Travis.   

Abstract

The conversion of inter-alpha-trypsin inhibitor (I alpha I) into active, acid-stable derivatives by proteolytic degradation has been tested with 10 different proteinases. Of these, only plasma kallikrein, cathepsin G, neutrophil elastase, and the Staphylococcus aureus V-8 proteinase were found to be effective, each releasing more than 50% of this activity. However, a strong correlation between inhibitor degradation and significant release of acid-stable activity could only be found with the V-8 enzyme. Inhibition kinetics for the interaction of native I alpha I, the inhibitory fragment released by digestion with S. aureus V-8 proteinase, or the related urinary trypsin inhibitor, with seven different proteinases indicated that all had essentially identical Ki values with an individual enzyme and, where measurements were possible, nearly identical second order association rate constants. Significantly, none of the five human proteinases tested, including trypsin, chymotrypsin, plasmin, neutrophil elastase, and cathepsin G, would appear to have low enough Ki values to be physiologically relevant. Thus, the role of native I alpha I or its degradation products in controlling a specific proteolytic activity is still unknown.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2475494

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Inter-alpha inhibitor proteins attenuate lipopolysaccharide-induced blood-brain barrier disruption and downregulate circulating interleukin 6 in mice.

Authors:  Aric F Logsdon; Michelle A Erickson; Xiaodi Chen; Joseph Qiu; Yow-Pin Lim; Barbara S Stonestreet; William A Banks
Journal:  J Cereb Blood Flow Metab       Date:  2019-06-24       Impact factor: 6.200

2.  TSG-6 potentiates the antitissue kallikrein activity of inter-alpha-inhibitor through bikunin release.

Authors:  Rosanna Forteza; Susana M Casalino-Matsuda; Maria Elena Monzon; Erik Fries; Marilyn S Rugg; Caroline M Milner; Anthony J Day
Journal:  Am J Respir Cell Mol Biol       Date:  2006-07-27       Impact factor: 6.914

3.  Inter-α inhibitor protein and its associated glycosaminoglycans protect against histone-induced injury.

Authors:  Hala Chaaban; Ravi S Keshari; Robert Silasi-Mansat; Narcis I Popescu; Padmaja Mehta-D'Souza; Yow-Pin Lim; Florea Lupu
Journal:  Blood       Date:  2015-01-28       Impact factor: 22.113

4.  Slow, reversible, coupled folding and binding of the spectrin tetramerization domain.

Authors:  S L Shammas; J M Rogers; S A Hill; J Clarke
Journal:  Biophys J       Date:  2012-11-20       Impact factor: 4.033

5.  Inter-alpha inhibitor protein administration improves survival from neonatal sepsis in mice.

Authors:  Kultar Singh; Ling Xiu Zhang; Kreso Bendelja; Ryan Heath; Shaun Murphy; Surendra Sharma; James F Padbury; Yow-Pin Lim
Journal:  Pediatr Res       Date:  2010-09       Impact factor: 3.756

6.  Inter-α inhibitor proteins maintain neutrophils in a resting state by regulating shape and reducing ROS production.

Authors:  Soe Soe Htwe; Hidenori Wake; Keyue Liu; Kiyoshi Teshigawara; Barbara S Stonestreet; Yow-Pin Lim; Masahiro Nishibori
Journal:  Blood Adv       Date:  2018-08-14

7.  Pharmacokinetics of Inter-Alpha Inhibitor Proteins and Effects on Hemostasis After Hypoxic-Ischemic Brain Injury in Neonatal Rats.

Authors:  Xiaodi Chen; Dawei Song; Sakura Nakada; Joseph Qiu; Karin Iwamoto; Ray H Chen; Yow-Pin Lim; William J Jusko; Barbara S Stonestreet
Journal:  Curr Pharm Des       Date:  2020       Impact factor: 3.116

8.  Expression and localization of Inter-alpha Inhibitors in rodent brain.

Authors:  X Chen; L Rivard; S Naqvi; S Nakada; J F Padbury; J Sanchez-Esteban; E G Stopa; Y-P Lim; B S Stonestreet
Journal:  Neuroscience       Date:  2016-03-08       Impact factor: 3.590

9.  Bikunin present in human peritoneal fluid is in part derived from the interaction of serum with peritoneal mesothelial cells.

Authors:  G J Thomas; S Yung; M Davies
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

10.  Characterization of uronic-acid-rich inhibitor of calcium oxalate crystallization isolated from rat urine.

Authors:  F Atmani; S R Khan
Journal:  Urol Res       Date:  1995
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.